Clinical Trial Update: Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of an inhaled HA solution for hereditary emphysema due to alpha-1 antitrypsin deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Emphysema

Drugs mentioned

• HA Inhalation Solution

Snippet

Sponsor: Gerard Turino | Conditions: Emphysema, Alpha 1-Antitrypsin Deficiency | Phase 2 | Status: COMPLETED